Published in TB and Outbreaks Week, January 14th, 2003
Peter Q. Eichacker, MD, of the critical care department, National Institutes of Health, Bethesda, Maryland, along with 9 associates, performed a retrospective analysis of 22 human clinical studies and 38 preclinical animal trials, along with a prospective large confirmatory animal investigation.
The investigators were testing their hypothesis that anti-inflammatory agents were efficacious in septic patients who had a higher risk of death and harmful in those with low risk. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week